SecBot SecBot
SECBOTREPLAY Home › Report › INKT

INKT · MiNK Therapeutics announced it will report Q3 2026 financial results on…

MiNK Therapeutics · PRESS-RELEASE filed Nov 2, 2026 at 16:35 ET

At the news

NEUTRALIMPACT 2/10

PRESS-RELEASE filed Nov 2, 2026 at 16:35 ET

MiNK Therapeutics announced it will report Q3 2026 financial results on November 11, 2026, before market open. The press release provides no financial data, only a forward-looking update on clinical programs for agenT-797 and strategic collaborations. Consensus estimates are EPS -$0.50 and revenue $875K, but no actual results are disclosed yet.

  • Q3 2026 earnings release scheduled for November 11, 2026 before market open
  • Conference call and webcast at 8:30 AM ET on November 11, 2026
  • No financial results disclosed in this press release
  • Consensus estimates: EPS -$0.50, revenue $875K (2 analysts)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access